Increasing Adoption Of Point-Of-Care Diagnostic Testing Is Boosting The Women’s Health Diagnostics Market

Womens Health Diagnostics Market


Women are more vulnerable to certain diseases, mostly related to menstrual disorders, osteoporosis, depression, obesity, and autoimmune diseases. Women’s major health issues are related to the reproductive system that includes infertility, menopause, polycystic ovarian syndrome, and cancers such as cervical cancer, breast cancer, and urological disorders.

Drivers & Restraints

The global market is anticipated to rise at a considerable rate during the forecast period. Factors such as growing awareness about various health-related disorders among women, rising incidence of various chronic and lifestyle disorders in women, and high prevalence of infectious diseases such as HIV and hepatitis in women across the globe are driving the growth of the market.

Sample Link Here:



Product Type-

Diagnostic Devices

Diagnostic Tests

Accessories & Consumables



Hospitals & Clinics

Home Care Settings

Diagnostic & Imaging Centers


Regional Analysis

The market has been segment into North America, South America, Europe, Asia-Pacific, and Middle East and Africa. North America commanded the largest share of the global women health diagnostics market.

Purchase Link Here:



Abbott Laboratories


Dickinson and Company

Carestream Health

  1. Hoffmann-La Roche AG

GE Healthcare

Hologic, Inc.

Koninklijke Philips N.V.

Quest Diagnostics Inc.